CA Stock MarketDetailed Quotes
INNO InnoCan Pharma Corp
- 0.230
- 0.0000.00%
15min DelayMarket Closed Nov 4 09:30 ET
65.71MMarket Cap-10952P/E (TTM)
0.230High0.230Low600Volume0.230Open0.230Pre Close138.00Turnover0.41052wk High0.00%Turnover Ratio285.69MShares0.18552wk Low-0.021EPS TTM50.97MFloat Cap1.650Historical HighLossP/E (Static)221.59MShs Float0.050Historical Low-0.023EPS LYR0.00%Amplitude--Dividend TTM9.58P/B1Lot Size--Div YieldTTM
InnoCan Pharma Corp Key Stats
EPS
According to the latest financial report of InnoCan Pharma Corp, the latest earnings per share (TTM) for the company is 0.00. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about InnoCan Pharma Corp's free cash flow? The latest report shows it as 672.00K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of InnoCan Pharma Corp shows that the company's current ratio is 3.22, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of InnoCan Pharma Corp, the quick ratio is 2.09, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of InnoCan Pharma Corp? The latest ROE figure is 7.54%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of InnoCan Pharma Corp, the total asset return on investment (ROA) is 3.80%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check InnoCan Pharma Corp's latest financial report to see how their gross margin is doing - currently at 92.53%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of InnoCan Pharma Corp, the net profit margin is 11.06%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data